SEC Filing Summary: Safety Shot, Inc. (8-K)
Business Context and Reporting Period
Company: Safety Shot, Inc. (Note: Input metadata listed "BONK, INC." but the filing text identifies the registrant as Safety Shot, Inc.)
Reporting Date: July 21, 2025 (Event Date); July 24, 2025 (Closing Date)
Reporting Period: Current Report on Form 8-K
Business Overview: The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Jupiter, FL. Its common stock (SHOT) and warrants (SHOTW) trade on The Nasdaq Capital Market.
Key Financial Metrics and Transaction Details
This filing reports a capital raise event rather than periodic financial performance. Key metrics related to the transaction include:
- Aggregate Gross Proceeds: Approximately $16.3 million (combined RD Offering and PIPE Offering).
- Registered Direct Offering (RD Offering): Issuance of 22,993,492 shares of Common Stock at $0.461 per share.
- Concurrent Private Placement (PIPE Offering): Issuance of unregistered warrants to purchase up to 45,986,984 shares of Common Stock.
- Warrant Terms: Exercise price of $0.461 per share; immediately exercisable; 5-year term.
- Placement Agent Fees: 8.0% cash fee, 1.0% expense allowance, $150,000 for legal/out-of-pocket expenses, plus 1,839,479 Placement Agent Warrants.
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for the Company's operations.
Material Changes
The primary material change is the significant increase in outstanding equity securities and potential dilution resulting from the July 24, 2025 closing of the RD Offering and PIPE Offering. The Company has entered into a Material Definitive Agreement (Securities Purchase Agreement) and a Placement Agency Agreement with Dominari Securities LLC.
Guidance, Outlook, and Risks
- Outlook: Management intends to use net proceeds for working capital and general corporate purposes.
- Regulatory Obligations: The Company agreed to file a Form S-1 registration statement for the resale of Common Warrant Shares within 10 days of the agreement, with effectiveness required within 45 days (or 75 days if a full review is issued).
- Risks/Contingencies: The Common Warrants and Placement Agent Warrants were issued unregistered under Section 4(a)(2) and Rule 506 exemptions. The filing notes that the descriptions of agreements are qualified by reference to the exhibits.
- Unusual Items: The filing includes a press release amendment issued on July 22, 2025, regarding the initial announcement.
Investor Verification Checklist
- Verify the exact number of shares issued (22,993,492) and the total warrant count (45,986,984 Common Warrants + 1,839,479 Placement Agent Warrants) to assess total dilution.
- Confirm the net proceeds after deducting the 9% cash/expense fees and legal costs from the $16.3 million gross proceeds.
- Review the attached Exhibits 10.1 and 10.2 for specific covenants, lock-up provisions, or redemption rights not detailed in the summary.
- Monitor the status of the Form S-1 registration statement for the warrant shares to ensure timely effectiveness as required by the Purchase Agreement.
- Check the July 22, 2025 press release (Exhibit 99.2) for any material amendments to the original offering terms.